|Place of Origin:||China|
|Certification:||COA, HPLC MR|
|Model Number:||HBY-Ciprofloxacin HCL|
|Minimum Order Quantity:||1KG|
|Packaging Details:||Aluminum Bag or 25KG/Fibre Drum|
|Delivery Time:||3-5 work days after your payment|
|Payment Terms:||Western Union, T/T, MoneyGram|
|Shelf Life:||2 YEARS||Storage:||2~8 Centigrade|
Pharmaceutical Bacterial Powder,
CAS 86483-48-9 Bacterial Powder,
Ciprofloxacin hcl powder
CAS 86483-48-9 Pharmaceutical Bacterial Powder Ciprofloxacin HCL
|Product Name||CAS 86483-48-9 Pharmaceutical Bacterial Powder Ciprofloxacin HCL|
|Storage||Store at 0-5°c|
|Deliver Time||Within 24 Hours After Receiving The Payment|
Ciprofloxacin hydrochloride is a fluoroquinolone antibiotic that is widely used as an antimicrobial and immunomodulatory agent. Its range of activity includes most strains of bacterial pathogens capable of inducing respiratory, urinary tract, gastrointestinal, and abdominal infections. It functions by inhibiting DNA gyrase (a type II topoisomerase) and topoisomerase IV, the enzymes responsible for negative supercoiling of chromosomes and DNA strand separation, thus blocking initiation of bacterial replication. Most recently Ciprofloxacin hydrochloride has been used in the management of postexposure inhalational anthrax and radiation combined injury resulting from nuclear disasters.
1. Ciprofloxacin is used to treat a wide variety of infections, including infections of bones and joints, endocarditis, gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections,prostatitis, anthrax, and chancroid.
2. Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa. For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Diseases Society of America for the treatment of community-acquired abdominal infections in adults. It also features prominently in treatment guidelines for acute pyelonephritis, complicated or hospital-acquired urinary tract infection, acute or chronic prostatitis,certain types of endocarditis, certain skin infections, and prosthetic joint infections.